Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.850
+0.040 (2.21%)
Nov 28, 2025, 1:00 PM EST - Market closed
Bionano Genomics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Bionano Genomics stock have a consensus rating of "Strong Buy" and an average price target of $6.33, which forecasts a 242.16% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $8.00.
Price Target: $6.33 (+242.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +278.38% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +494.59% | Aug 18, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +332.43% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +440.54% | Apr 9, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $1 → $4 | Hold | Maintains | $1 → $4 | +116.22% | Apr 2, 2025 |
Financial Forecast
Revenue This Year
28.70M
from 30.78M
Decreased by -6.75%
Revenue Next Year
35.74M
from 28.70M
Increased by 24.54%
EPS This Year
-6.23
from -88.13
EPS Next Year
-4.15
from -6.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.2M | 42.7M | |||
| Avg | 28.7M | 35.7M | |||
| Low | 27.0M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.0% | 48.6% | |||
| Avg | -6.7% | 24.5% | |||
| Low | -12.4% | 2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.87 | -3.01 | |||
| Avg | -6.23 | -4.15 | |||
| Low | -6.34 | -4.61 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.